Publicaciones en las que colabora con Arantzazu Arrospide Elgarresta (21)

2022

  1. Estimation of the epidemiology of dementia and associated neuropsychiatric symptoms by applying machine learning to real-world data

    Revista de Psiquiatria y Salud Mental, Vol. 15, Núm. 3, pp. 167-175

2021

  1. Validity of a computerized population registry of dementia based on clinical databases

    Neurologia, Vol. 36, Núm. 6, pp. 418-425

2020

  1. Economic evaluation of supplementing the diet with Souvenaid in patients with prodromal Alzheimer’s disease

    Alzheimer's Research and Therapy, Vol. 12, Núm. 1

  2. Validation of Random Forest Machine Learning Models to Predict Dementia-Related Neuropsychiatric Symptoms in Real-World Data

    Journal of Alzheimer's Disease, Vol. 77, Núm. 2, pp. 855-864

2019

  1. Dementia-related neuropsychiatric symptoms: Inequalities in pharmacological treatment and institutionalization

    Neuropsychiatric Disease and Treatment, Vol. 15, pp. 2027-2034

  2. Gender and socioeconomic inequalities in the implementation of the Basque programme for multimorbid patients

    European Journal of Public Health, Vol. 29, Núm. 4, pp. 681-686

  3. Impact of stratification on the effectiveness of a comprehensive patient-centered strategy for multimorbid patients

    Health Services Research, Vol. 54, Núm. 2, pp. 466-473

  4. The impact of patient identification on an integrated program of palliative care in Basque Country

    Atencion Primaria, Vol. 51, Núm. 2, pp. 80-90

2018

  1. Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model

    BMC Cancer, Vol. 18, Núm. 1

2017

  1. Evaluación de la implementación de un programa integrado de atención a las enfermedades del aparato locomotor

    Reumatologia Clinica, Vol. 13, Núm. 4, pp. 189-196

  2. Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model

    BMC Public Health, Vol. 18, Núm. 1

  3. Incorporating Budget Impact Analysis in the Implementation of Complex Interventions: A Case of an Integrated Intervention for Multimorbid Patients within the CareWell Study

    Value in Health, Vol. 20, Núm. 1, pp. 100-106

  4. Relevance of clinical judgement and risk stratification in the success of integrated care for multimorbid patients

    Documentos de trabajo ( FEDEA )

  5. Valoración del coste económico del cáncer colorrectal según estadio tumoral

    Cirugia Espanola, Vol. 95, Núm. 2, pp. 89-96

2016

  1. Economic evaluation of the breast cancer screening programme in the Basque Country: Retrospective cost-effectiveness and budget impact analysis

    BMC Cancer, Vol. 16, Núm. 1

  2. Modeling approach to managing the deployment of integrated organizational models for multi-morbid patients in the CareWell study. The Basque Country case

    International Journal of Integrated Care, Vol. 16, Núm. 6, pp. 266

2015

  1. Coste del tratamiento del cáncer de mama por estadío clínico en el País Vasco

    Revista Espanola de Salud Publica, Vol. 89, Núm. 1, pp. 93-97

  2. Fitting the epidemiology and neuropathology of the early stages of Alzheimer's disease to prevent dementia

    Alzheimer's Research and Therapy, Vol. 7, Núm. 1

  3. Projecting Burden of Dementia in Spain, 2010-2050: Impact of Modifying Risk Factors

    Journal of Alzheimer's Disease, Vol. 48, Núm. 3, pp. 721-730

  4. Regional variability in changes in the incidence of hip fracture in the Spanish population (2000–2012)

    Osteoporosis International, Vol. 26, Núm. 5, pp. 1491-1497